Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -547,029 | -439,495 | -383,092 | -165,911 | -892,869 |
| Depreciation Amortization | 110,878 | 95,226 | 78,057 | 12,869 | 70,507 |
| Income taxes - deferred | -936 | N/A | N/A | N/A | -801 |
| Accounts receivable | -4,725 | -6,101 | -1,102 | -6,770 | 50,068 |
| Accounts payable and accrued liabilities | 4,771 | -31,099 | N/A | N/A | -1,183 |
| Other Working Capital | -89,670 | -91,849 | 6,192 | 312 | 29,837 |
| Other Operating Activity | 207,126 | 196,168 | 126,296 | 70,241 | 448,941 |
| Operating Cash Flow | $-319,585 | $-277,150 | $-173,649 | $-89,259 | $-295,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61,893 | -48,240 | -33,742 | -6,710 | -36,373 |
| Net Acquisitions | -5,400 | -5,400 | -5,400 | -5,400 | N/A |
| Purchase Of Investment | 4,519 | 3,951 | N/A | N/A | N/A |
| Other Investing Activity | 538 | 538 | 191 | 0 | -44,320 |
| Investing Cash Flow | $-62,236 | $-49,151 | $-38,951 | $-12,110 | $-80,693 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -897 | -694 | -494 | -294 | -1,295 |
| Common Stock Issued | 84 | 84 | 84 | 70 | 93 |
| Other Financing Activity | -926 | -926 | -661 | -621 | -2,014 |
| Financing Cash Flow | $-1,739 | $-1,536 | $-1,071 | $-845 | $-3,216 |
| Exchange Rate Effect | -281 | -208 | -173 | -157 | -588 |
| Beginning Cash Position | 989,584 | 989,584 | 989,584 | 989,584 | 1,369,581 |
| End Cash Position | 605,743 | 661,539 | 775,740 | 932,724 | 989,584 |
| Net Cash Flow | $-383,841 | $-328,045 | $-213,844 | $-56,860 | $-379,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -319,585 | -277,150 | -173,649 | -89,259 | -295,500 |
| Capital Expenditure | -62,541 | -48,831 | -33,742 | -6,710 | -40,801 |
| Free Cash Flow | -382,126 | -325,981 | -207,391 | -95,969 | -336,301 |